Skip to content

Clinical trials

Recruiting Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Recruiting Country / region: United States Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20161
20172
20183
20195
20205
20217
202218
202314
202423
202532
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting132

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
Mayo Clinic6
University of Texas Southwestern Medical Center6
National Cancer Institute (NCI)5
City of Hope Medical Center3
VA Office of Research and Development3
Anwaar Saeed2
AstraZeneca2
DualityBio Inc.2
Eureka Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular132
Liver Neoplasms24
Colorectal Neoplasms22
Melanoma21
Carcinoma, Non-Small-Cell Lung18
Carcinoma, Renal Cell18
Cholangiocarcinoma14
Stomach Neoplasms14
Ovarian Neoplasms13
Endometrial Neoplasms12

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.